Systemic mastocytosis is a rare health condition in which too many mast cells (a type of immune system cell) build up in the body, causing allergic reactions and other health issues. This disorder ...

In September of 2000, the world's leading experts in MC met to discuss and present data at the "Year 2000 Working Conference on Mastocytosis," held in Vienna, Austria. Table 1 presents a uniform ...

A standard treatment for mastocytosis is difficult to apply to individual patients based on the variable clinical course. A general consensus for using antimediator agents such as antihistamines ...

An observational, multicenter, real-world study conducted at 12 screening sites in Germany has reported a 17.6% higher cancer detection rate among women aged 50–69 who received AI-supported ...

TL-895 is under clinical development by Telios Pharma and currently in Phase II for Systemic Mastocytosis. According to GlobalData, Phase II drugs for Systemic Mastocytosis have a 64% phase transition ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...